BioCentury
ARTICLE | Clinical News

Azilsartan medoxomil regulatory update

October 8, 2012 7:00 AM UTC

Takeda said that within the first 8 months of this year, it submitted a regulatory application for azilsartan medoxomil in Hong Kong to treat hypertension. The oral angiotensin II type 1 (AT1) recept...